1. Home
  2. NSPR vs KF Comparison

NSPR vs KF Comparison

Compare NSPR & KF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NSPR
  • KF
  • Stock Information
  • Founded
  • NSPR 2005
  • KF 1984
  • Country
  • NSPR United States
  • KF United States
  • Employees
  • NSPR N/A
  • KF N/A
  • Industry
  • NSPR Medical/Dental Instruments
  • KF Investment Managers
  • Sector
  • NSPR Health Care
  • KF Finance
  • Exchange
  • NSPR Nasdaq
  • KF Nasdaq
  • Market Cap
  • NSPR 79.7M
  • KF 83.7M
  • IPO Year
  • NSPR N/A
  • KF N/A
  • Fundamental
  • Price
  • NSPR $2.36
  • KF $21.59
  • Analyst Decision
  • NSPR Strong Buy
  • KF
  • Analyst Count
  • NSPR 2
  • KF 0
  • Target Price
  • NSPR $4.50
  • KF N/A
  • AVG Volume (30 Days)
  • NSPR 50.0K
  • KF 18.4K
  • Earning Date
  • NSPR 05-09-2025
  • KF 01-01-0001
  • Dividend Yield
  • NSPR N/A
  • KF N/A
  • EPS Growth
  • NSPR N/A
  • KF N/A
  • EPS
  • NSPR N/A
  • KF N/A
  • Revenue
  • NSPR $7,027,000.00
  • KF N/A
  • Revenue This Year
  • NSPR $28.93
  • KF N/A
  • Revenue Next Year
  • NSPR $172.18
  • KF N/A
  • P/E Ratio
  • NSPR N/A
  • KF N/A
  • Revenue Growth
  • NSPR 8.49
  • KF N/A
  • 52 Week Low
  • NSPR $2.07
  • KF $18.30
  • 52 Week High
  • NSPR $3.80
  • KF $25.56
  • Technical
  • Relative Strength Index (RSI)
  • NSPR 38.53
  • KF 64.13
  • Support Level
  • NSPR $2.31
  • KF $21.35
  • Resistance Level
  • NSPR $2.69
  • KF $21.86
  • Average True Range (ATR)
  • NSPR 0.18
  • KF 0.34
  • MACD
  • NSPR -0.02
  • KF 0.08
  • Stochastic Oscillator
  • NSPR 10.42
  • KF 83.99

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About KF Korea Fund Inc. (The) New

Korea Fund Inc is a closed-end, non-diversified management investment company. Its investment objective is to seek long-term capital appreciation through investment in securities, equity securities, of Korean companies. Its portfolio consists of the different sectors such as the auto components, banks, beverages, chemicals, aerospace and defense, insurance, machinery, and others.

Share on Social Networks: